Efficacy, safety and immunogenicity of a human rotavirus vaccine (RIX4414) in Hong Kong children up to three years of age: A randomized, controlled trial
Publication in refereed journal


引用次數
替代計量分析
.

其它資訊
摘要Background: A phase III, double-blind, randomized, controlled trial was conducted in Hong Kong to evaluate the efficacy, safety and immunogenicity of a human rotavirus vaccine, RIX4414 (Rotarix (TM)) against severe rotavirus gastroenteritis in children up to three years of age.
著者Lau YL, Nelson EAS, Poon KH, Chan PKS, Chiu S, Sung R, Leung CW, Ng D, Ma YM, Chan D, Lee TL, Tang J, Kwan YW, Ip P, Ho M, Fung LWE, Tang HW, Suryakiran PV, Han HH, Bock H
期刊名稱Vaccine
出版年份2013
月份4
日期26
卷號31
期次18
出版社ELSEVIER SCI LTD
頁次2253 - 2259
國際標準期刊號0264-410X
電子國際標準期刊號1873-2518
語言英式英語
關鍵詞Efficacy; Gastroenteritis; Hong Kong; Intussusception; Rotavirus; Safety
Web of Science 學科類別Immunology; IMMUNOLOGY; Medicine, Research & Experimental; MEDICINE, RESEARCH & EXPERIMENTAL; Research & Experimental Medicine

上次更新時間 2020-18-10 於 01:17